4.7 Article

RNN-based longitudinal analysis for diagnosis of Alzheimer's disease

期刊

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.compmedimag.2019.01.005

关键词

Alzheimer's disease diagnosis; Longitudinal analysis; Convolutional neural networks (CNNs); Recurrent neural network; Magnetic resonance images

资金

  1. National Natural Science Foundation of China (NSFC) [6181101049, 61375112, 61773263]
  2. National Key Research and Development Program of China [2016YFC0100903]
  3. National Key Basic Research Program of China (973 Project) [2015CB931802]
  4. SMC Excellent Young Faculty program of SJTU
  5. National Institute on Aging
  6. National Institute of Biomedical Imaging and Bioengineering
  7. Abbott
  8. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  9. AstraZeneca AB
  10. Bayer Schering Pharma AG
  11. Bristol-Myers Squibb
  12. Eisai Global Clinical Development
  13. Elan Corporation
  14. Genentech
  15. GE Healthcare
  16. GlaxoSmithKline
  17. Innogeneticsjohnson
  18. Johnson
  19. Eli Lilly and Co.
  20. Medpace, Inc.
  21. Merck and Co., Inc.
  22. Novartis AG
  23. Pfizer Inc.
  24. F. Hoffman-La Roche
  25. Schering-Plough
  26. Synarc, Inc.
  27. Alzheimer's Association
  28. Alzheimer's Drug Discovery Foundation
  29. U.S. Food and Drug Administration

向作者/读者索取更多资源

Alzheimer's disease (AD) is an irreversible neurodegenerative disorder with progressive impairment of memory and other mental functions. Magnetic resonance images (MRI) have been widely used as an important imaging modality of brain for AD diagnosis and monitoring the disease progression. The longitudinal analysis of sequential MRIs is important to model and measure the progression of the disease along the time axis for more accurate diagnosis. Most existing methods extracted the features capturing the morphological abnormalities of brain and their longitudinal changes using MRIs and then designed a classifier to discriminate different groups. However, these methods have several limitations. First, since the feature extraction and classifier model are independent, the extracted features may not capture the full characteristics of brain abnormalities related to AD. Second, longitudinal MR images may be missing at some time points for some subjects, which results in difficulties for extraction of consistent features for longitudinal analysis. In this paper, we present a classification framework based on combination of convolutional and recurrent neural networks for longitudinal analysis of structural MR images in AD diagnosis. First, Convolutional Neural Networks (CNN) is constructed to learn the spatial features of MR images for the classification task. After that, recurrent Neural Networks (RNN) with cascaded three bidirectional gated recurrent units (BGRU) layers is constructed on the outputs of CNN at multiple time points for extracting the longitudinal features for AD classification. Instead of independently performing feature extraction and classifier training, the proposed method jointly learns the spatial and longitudinal features and disease classifier, which can achieve optimal performance. In addition, the proposed method can model the longitudinal analysis using RNN from the imaging data at various time points. Our method is evaluated with the longitudinal TI-weighted MR images of 830 participants including 198 AD, 403 mild cognitive impairment (MCI), and 229 normal controls (NC) subjects from Alzheimer's Disease Neuroimaging Initiative (ADNI) database. Experimental results show that the proposed method achieves classification accuracy of 91.33% for AD vs. NC and 71.71% for pMCI vs. sMCI, demonstrating the promising performance for longitudinal MR image analysis. (C) 2019 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据